JP5315056B2
(ja )
2013-10-16
固結抑制粒状製剤
EP0966969A4
(en )
2000-04-26
ANTI-STRESS ACTIVE AND FUNCTIONAL NUTRIENTS WITH ANTI-STRESS EFFECTS
TN2009000317A1
(en )
2010-12-31
Solid preparation comprising alogliptin and pioglitazone
WO2007067582A3
(en )
2007-08-02
Process for manufacturing chewable dosage forms for drug delivery and products thereof
JP2011506587A5
(cg-RX-API-DMAC7.html )
2012-02-16
WO2007014124A3
(en )
2007-10-04
High drug load formulations and dosage forms
JP2005511619A5
(cg-RX-API-DMAC7.html )
2006-01-05
JP2007517039A5
(cg-RX-API-DMAC7.html )
2008-02-21
WO2010098627A2
(ko )
2010-09-02
약제학적 제제
TW201208704A
(en )
2012-03-01
Palatable pharmaceutical composition
WO2005004860A3
(fr )
2005-04-14
Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
CA2489140A1
(en )
2004-11-18
Dosage form containing pantoprazole as active ingredient
JP2018039810A5
(cg-RX-API-DMAC7.html )
2018-05-17
CA2549185A1
(en )
2005-07-07
Peptide inhibiting angiotensin converting enzyme
GB2443793B
(en )
2010-12-01
Product, method of manufacture and use
Swamivelmanickam et al.
2010
Mouth dissolving tablets: an overview
KR20130113348A
(ko )
2013-10-15
미립자 코팅 제제
RU2686694C2
(ru )
2019-04-30
Комбинированный лекарственный препарат в форме шипучих таблеток и способ его получения
WO2004096125A3
(en )
2004-12-23
Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem
WO2004004705A3
(en )
2004-03-11
Pharmaceutical formulations for preparing drink products
JP2006265231A5
(cg-RX-API-DMAC7.html )
2009-02-19
JP2011079789A
(ja )
2011-04-21
アンジオテンシンi変換酵素阻害剤
JP2006160721A5
(cg-RX-API-DMAC7.html )
2008-04-17
WO2006125496A3
(en )
2007-04-12
Pharmaceutical formulations comprising active pharmaceutical principles absorbed on titanium dioxide nanoparticles
JP2008088101A
(ja )
2008-04-17
抗疲労剤